Stefan Romeijn
Papers
1
Total Citations
5
H-Index
1
About
Stefan Romeijn is a pharmaceutical scientist whose research focuses on the stability and formulation of biopharmaceuticals, particularly monoclonal antibodies. His work addresses critical challenges in the compounding and administration of these complex drugs, ensuring patient safety and therapeutic efficacy. Romeijn’s most-cited study, "Aggregate Formation and Antibody Stability in Infusion Bags: The Impact of Manual and Robotic Compounding of Monoclonal Antibodies" (2023), has garnered 5 citations and provides pivotal insights into how compounding methods—whether manual or robotic—affect protein aggregation and stability. This research is vital for hospital pharmacies and the pharmaceutical industry, as it informs best practices for handling sensitive biologics. By systematically evaluating the physical and chemical stresses during compounding, Romeijn’s contributions help mitigate risks of immunogenicity and loss of drug activity. His work bridges formulation science and clinical practice, offering practical solutions for maintaining antibody integrity. Romeijn’s focus on real-world compounding scenarios underscores his commitment to translating fundamental stability principles into actionable guidelines, making him a key voice in the advancement of safe biotherapeutic administration.
Research Focus
Key Achievements
Top Papers
- 1